21TY | pdb_000021ty

Cryo-EM structure of Free fatty acid receptor 2 (FFA2)-ARK1 with GLPG0974


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.93 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 21TY

This is version 1.0 of the entry. See complete history

Literature

Universal pipeline for high-resolution GPCR structure determination.

Kojima, A.Kawakami, K.Kobayashi, N.Kobayashi, K.Matsui, T.E.Uemoto, K.Gu, Y.Narita, T.J.Kugawa, M.Fukuda, M.Kato, H.E.

(2026) Nat Struct Mol Biol 

  • DOI: https://doi.org/10.1038/s41594-026-01869-6
  • Primary Citation Related Structures: 
    21TY

  • PubMed Abstract: 

    G protein-coupled receptors (GPCRs) regulate human physiology and are major drug targets. Although cryo-electron microscopy has accelerated GPCR structural biology, inactive-state structures remain difficult because current fusion-based strategies often require extensive experimental screening to identify rigid constructs suitable for high-resolution reconstruction. Here we introduce a universal pipeline that integrates an in silico fusion construct screening program, NOAH (nonexperimental, artificial-intelligence-assisted, high-throughput construct screening for structural analysis), with a de novo designed fusion protein, ARK1 (artificially designed fiducial marker). NOAH enabled structure determination of vasopressin V2 receptor bound to the antagonist tolvaptan or partial agonist OPC51803 and bradykinin B2 receptor bound to the antagonist icatibant, revealing receptor activation and inhibition mechanisms. Coupling NOAH to ARK1 improved the V2 receptor-tolvaptan map and enabled high-resolution structures of lysophosphatidic acid receptor 2 bound to Ki16425 and free fatty acid receptor 2 bound to GLPG0974. NOAH-ARK1 minimizes trial-and-error construct optimization and provides a broadly applicable route for GPCR structural analysis and drug discovery.


  • Organizational Affiliation
    • Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan.

Macromolecule Content 

  • Total Structure Weight: 86.05 kDa 
  • Atom Count: 5,388 
  • Modeled Residue Count: 662 
  • Deposited Residue Count: 748 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Free fatty acid receptor 2,human free fatty acid receptor 2 (FFA2) fused with de novo designed ARK1748Homo sapiensMutation(s): 0 
Gene Names: FFAR2FFA2GPCR43GPR43
UniProt & NIH Common Fund Data Resources
Find proteins for O15552 (Homo sapiens)
Explore O15552 
Go to UniProtKB:  O15552
PHAROS:  O15552
GTEx:  ENSG00000126262 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO15552
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1LYD
(Subject of Investigation/LOI)

Query on A1LYD



Download:Ideal Coordinates CCD File
B [auth A]GLPG-0974
C25 H25 Cl N2 O4 S
MPMKMQHJHDHPBE-RUZDIDTESA-N

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.93 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
RECONSTRUCTIONcryoSPARC
MODEL REFINEMENTREFMAC5.8.0425

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Japan Science and TechnologyJapanJPMJAX222F
Japan Science and TechnologyJapanJPMJPR24OF
Japan Society for the Promotion of Science (JSPS)Japan25K09525
Japan Society for the Promotion of Science (JSPS)Japan24H02262
Japan Society for the Promotion of Science (JSPS)Japan25H01338
Japan Society for the Promotion of Science (JSPS)JapanJP24KJ0981

Revision History  (Full details and data files)

  • Version 1.0: 2026-09-09
    Type: Initial release